Education
About Us
Working with TipRanks
Follow Us
Health Catalyst (HCAT)
:HCAT
HCAT Stock Chart & Stats
$3.23
$0.34(4.94%)
At close: 4:00 PM EST
$3.23
$0.34(4.94%)
Day’s Range― - ―
52-Week Range$2.52 - $9.24
Previous CloseN/A
Volume315.36K
Average Volume (3M)507.43K
Market Cap
$227.31M
Enterprise Value$337.94M
Total Cash (Recent Filing)$97.34M
Total Debt (Recent Filing)$172.79M
Price to Earnings (P/E)―
Beta1.37
Next Earnings
Nov 10, 2025EPS Estimate
0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.04
Shares Outstanding70,373,630
10 Day Avg. Volume557,727
30 Day Avg. Volume507,429
Financial Highlights & Ratios
PEG Ratio0.14
Price to Book (P/B)1.17
Price to Sales (P/S)1.39
P/FCF Ratio-231.38
Enterprise Value/Market Cap1.49
Enterprise Value/Revenue1.07
Enterprise Value/Gross Profit2.36
Enterprise Value/Ebitda-9.51
Forecast
1Y Price Target
$4.25Price Target Upside31.58% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
Bulls Say, Bears Say
Bulls Say
Client SpendingHospital executives expect their spending with HCAT to either remain steady or increase, with some considering purchasing more modules to analyze costs.
Corporate CultureConversations with Health Catalyst employees reinforced the view of the company's unique corporate culture, which is seen as core to the company's long-term growth model.
Technology And InnovationHealth Catalyst is shifting the business to high-margin technology and integrating AI more heavily into its offerings, reducing reliance on lower-margin professional services.
Bears Say
CEO DepartureCEO Dan Burton, the founder, will be stepping down, which has contributed to the stock pulling back significantly.
Challenging EnvironmentThe hospital buying environment is expected to become more challenging due to the Big Beautiful Bill Act, affecting future growth prospects.
Revenue GuidanceHealth Catalyst cut its revenue guidance for the year, removing all organic growth from its outlook.
Health Catalyst News
HCAT FAQ
What was Health Catalyst’s price range in the past 12 months?
Health Catalyst lowest stock price was $2.52 and its highest was $9.24 in the past 12 months.
What is Health Catalyst’s market cap?
Health Catalyst’s market cap is $227.31M.
When is Health Catalyst’s upcoming earnings report date?
Health Catalyst’s upcoming earnings report date is Nov 10, 2025 which is in 8 days.
How were Health Catalyst’s earnings last quarter?
Health Catalyst released its earnings results on Aug 07, 2025. The company reported $0.04 earnings per share for the quarter, beating the consensus estimate of $0.033 by $0.007.
Is Health Catalyst overvalued?
According to Wall Street analysts Health Catalyst’s price is currently Undervalued.
Does Health Catalyst pay dividends?
Health Catalyst does not currently pay dividends.
What is Health Catalyst’s EPS estimate?
Health Catalyst’s EPS estimate is 0.06.
How many shares outstanding does Health Catalyst have?
Health Catalyst has 70,373,630 shares outstanding.
What happened to Health Catalyst’s price movement after its last earnings report?
Health Catalyst reported an EPS of $0.04 in its last earnings report, beating expectations of $0.033. Following the earnings report the stock price went down -23.306%.
Which hedge fund is a major shareholder of Health Catalyst?
Currently, no hedge funds are holding shares in HCAT
Health Catalyst Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.25 (31.58% Upside)
$4.25 (31.58% Upside)
Blogger Sentiment
Bullish
HCAT Sentiment 70%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 143.6K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▲ 1.6%
Last 30 Days <0.1%
Last 30 Days <0.1%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-58.42%
12-Months-Change
Fundamentals
Return on Equity
-28.42%
Trailing 12-Months
Asset Growth
-10.92%
Trailing 12-Months
Company Description
Health Catalyst
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accuracy; population health management identifies improvement across the care continuum as well as actionable guidance for success and automated workflows; financial transformation providing costing and labor productivity insights and revenue capture; quality and safety improvement using clinical quality and patient safety data, analytics, and expert services; and national data ecosystem for thought leadership and mutual knowledge exchange to transform care delivery through next-gen insights. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah.
HCAT Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects a mix of positive performance metrics and strategic initiatives aimed at improving profitability, alongside significant challenges due to macroeconomic factors and funding cuts impacting revenue growth and client contracts.View all HCAT earnings summariesHCAT Stock 12 Month Forecast
Average Price Target
$4.25
▲(31.58% Upside)
Technical Analysis
HealthStream
―
OptimizeRx
―
Evolent Health
―
SOPHiA GENETICS
―
Definitive Healthcare Corp
―
Ownership Overview
5.77% Insiders
19.39% Mutual Funds
0.28% Other Institutional Investors
63.08% Public Companies and
Individual Investors